These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1256 related items for PubMed ID: 29955789

  • 1. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles.
    Thomsen LH, Kesmodel US, Erb K, Bungum L, Pedersen D, Hauge B, Elbæk HO, Povlsen BB, Andersen CY, Humaidan P.
    Hum Reprod; 2018 Aug 01; 33(8):1506-1516. PubMed ID: 29955789
    [Abstract] [Full Text] [Related]

  • 2. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.
    Uyanik E, Mumusoglu S, Polat M, Yarali Ozbek I, Esteves SC, Humaidan P, Yarali H.
    Hum Reprod; 2023 Feb 01; 38(2):225-236. PubMed ID: 36478179
    [Abstract] [Full Text] [Related]

  • 3. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N, Abdennebi I, Porcu-Buisson G, Chevalier N, Descat E, Piétin-Vialle C, Goro S, Brussieux M, Pinto M, Pasquier M, Bry-Gauillard H.
    Hum Reprod; 2023 May 02; 38(5):927-937. PubMed ID: 36864699
    [Abstract] [Full Text] [Related]

  • 4. Rectal progesterone administration secures a high ongoing pregnancy rate in a personalized Hormone Replacement Therapy Frozen Embryo Transfer (HRT-FET) protocol: a prospective interventional study.
    Alsbjerg B, Jensen MB, Povlsen BB, Elbaek HO, Laursen RJ, Kesmodel US, Humaidan P.
    Hum Reprod; 2023 Nov 02; 38(11):2221-2229. PubMed ID: 37759346
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial.
    Cédrin-Durnerin I, Carton I, Massin N, Chevalier N, Dubourdieu S, Bstandig B, Michelson X, Goro S, Jung C, Guivarc'h-Lévêque A.
    Hum Reprod; 2024 Sep 01; 39(9):1979-1986. PubMed ID: 39008826
    [Abstract] [Full Text] [Related]

  • 6. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
    Loreti S, Thiele K, De Brucker M, Olsen C, Centelles-Lodeiro J, Bourgain C, Waelput W, Tournaye H, Griesinger G, Raes J, Vieira-Silva S, Arck P, Blockeel C, Mackens S.
    Hum Reprod; 2024 Feb 01; 39(2):403-412. PubMed ID: 38110714
    [Abstract] [Full Text] [Related]

  • 7. Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study.
    Álvarez M, Gaggiotti-Marre S, Martínez F, Coll L, García S, González-Foruria I, Rodríguez I, Parriego M, Polyzos NP, Coroleu B.
    Hum Reprod; 2021 May 17; 36(6):1552-1560. PubMed ID: 33686413
    [Abstract] [Full Text] [Related]

  • 8. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
    Griesinger G, Blockeel C, Sukhikh GT, Patki A, Dhorepatil B, Yang DZ, Chen ZJ, Kahler E, Pexman-Fieth C, Tournaye H.
    Hum Reprod; 2018 Dec 01; 33(12):2212-2221. PubMed ID: 30304457
    [Abstract] [Full Text] [Related]

  • 9. Psychosocial wellbeing shortly after allocation to a freeze-all strategy compared with a fresh transfer strategy in women and men: a sub-study of a randomized controlled trial.
    Pilegaard SP, Schmidt L, Stormlund S, Koert E, Bogstad JW, Prætorius L, Nielsen HS, la Cour Freiesleben N, Sopa N, Klajnbard A, Humaidan P, Bergh C, Englund ALM, Løssl K, Pinborg A.
    Hum Reprod; 2023 Nov 02; 38(11):2175-2186. PubMed ID: 37742131
    [Abstract] [Full Text] [Related]

  • 10. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, van Golde RJT, Hoek A, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Torrance HL, Broekmans FJM, OPTIMIST study group.
    Hum Reprod; 2019 Jun 04; 34(6):1030-1041. PubMed ID: 31125412
    [Abstract] [Full Text] [Related]

  • 11. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC, Yarali H, Vuong LN, Carvalho JF, Özbek İY, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C.
    Hum Reprod; 2021 Jul 19; 36(8):2157-2169. PubMed ID: 34179973
    [Abstract] [Full Text] [Related]

  • 12. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS, Warzecha AK, Nielsen MV, Andersen CY, Holt MD, Petersen MR, Sopa N, Zedeler A, Englund AL, Pinborg A, Grøndahl ML, Skouby SO, Macklon NS.
    Hum Reprod; 2023 Nov 02; 38(11):2154-2165. PubMed ID: 37699851
    [Abstract] [Full Text] [Related]

  • 13. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
    Colombo C, Pistoljevic-Kristiansen N, Saupstad M, Bergenheim SJ, Spangmose AL, Klajnbard A, la Cour Freiesleben N, Løkkegaard EC, Englund AL, Husth M, Breth Knudsen U, Alsbjerg B, Prætorius L, Løssl K, Schmidt L, Pinborg A.
    Hum Reprod; 2023 Oct 03; 38(10):1970-1980. PubMed ID: 37634089
    [Abstract] [Full Text] [Related]

  • 14. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE.
    Hum Reprod; 2019 Jun 04; 34(6):1042-1054. PubMed ID: 31119299
    [Abstract] [Full Text] [Related]

  • 15. Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles).
    Vinsonneau L, Labrosse J, Porcu-Buisson G, Chevalier N, Galey J, Ahdad N, Ayel JP, Rongières C, Bouet PE, Mathieu d'Argent E, Cédrin-Durnerin I, Pessione F, Massin N.
    Hum Reprod Open; 2022 Jun 04; 2022(2):hoac007. PubMed ID: 35274060
    [Abstract] [Full Text] [Related]

  • 16. Dydrogesterone and 20α-dihydrodydrogesterone plasma levels on day of embryo transfer and clinical outcome in an anovulatory programmed frozen-thawed embryo transfer cycle: a prospective cohort study.
    Neumann K, Masuch A, Vonthein R, Depenbusch M, Schultze-Mosgau A, Eggersmann TK, Griesinger G.
    Hum Reprod; 2022 May 30; 37(6):1183-1193. PubMed ID: 35323905
    [Abstract] [Full Text] [Related]

  • 17. Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials.
    Griesinger G, Blockeel C, Pierzynski P, Tournaye H, Višňová H, Humberstone A, Terrill P, Pohl O, Garner E, Donnez J, Loumaye E.
    Hum Reprod; 2021 Mar 18; 36(4):1007-1020. PubMed ID: 33534895
    [Abstract] [Full Text] [Related]

  • 18. Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles.
    Racca A, Vanni VS, Somigliana E, Reschini M, Viganò P, Santos-Ribeiro S, Drakopoulos P, Tournaye H, Verheyen G, Papaleo E, Candiani M, Blockeel C.
    Hum Reprod; 2021 Aug 18; 36(9):2463-2472. PubMed ID: 34223890
    [Abstract] [Full Text] [Related]

  • 19. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
    Maheshwari A, Bell JL, Bhide P, Brison D, Child T, Chong HY, Cheong Y, Cole C, Coomarasamy A, Cutting R, Hardy P, Hamoda H, Juszczak E, Khalaf Y, Kurinczuk JJ, Lavery S, Linsell L, Macklon N, Mathur R, Pundir J, Raine-Fenning N, Rajkohwa M, Scotland G, Stanbury K, Troup S, Bhattacharya S.
    Hum Reprod; 2022 Mar 01; 37(3):476-487. PubMed ID: 34999830
    [Abstract] [Full Text] [Related]

  • 20. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.